National Health Investors, Inc. (NYSE:NHI) Given Consensus Rating of “Buy” by Brokerages

Shares of National Health Investors, Inc. (NYSE:NHI) have been given an average recommendation of “Buy” by the six analysts that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $86.50.

A number of brokerages have issued reports on NHI. Truist Financial boosted their price target on National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a report on Monday, December 15th. Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a research note on Monday, December 29th. KeyCorp raised their price target on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. Cantor Fitzgerald set a $85.00 price objective on shares of National Health Investors in a report on Monday. Finally, Wells Fargo & Company increased their target price on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in NHI. JPMorgan Chase & Co. boosted its holdings in National Health Investors by 305.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock worth $84,389,000 after buying an additional 906,479 shares during the last quarter. Norges Bank purchased a new position in shares of National Health Investors in the second quarter valued at approximately $49,775,000. M Holdings Securities Inc. acquired a new stake in shares of National Health Investors in the second quarter worth approximately $36,607,000. Balyasny Asset Management L.P. increased its position in shares of National Health Investors by 66.9% during the second quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock worth $43,121,000 after purchasing an additional 246,486 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in National Health Investors by 481.3% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 236,383 shares of the real estate investment trust’s stock valued at $18,792,000 after purchasing an additional 195,716 shares during the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Price Performance

NYSE:NHI opened at $77.96 on Thursday. The firm’s fifty day moving average is $77.35 and its two-hundred day moving average is $75.63. The firm has a market cap of $3.71 billion, a price-to-earnings ratio of 24.59, a PEG ratio of 2.85 and a beta of 0.67. The company has a debt-to-equity ratio of 0.74, a quick ratio of 10.64 and a current ratio of 10.64. National Health Investors has a one year low of $65.13 and a one year high of $80.56.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The business had revenue of $83.36 million during the quarter, compared to analyst estimates of $85.66 million. During the same quarter last year, the business posted $1.03 EPS. The company’s revenue was down 1.8% on a year-over-year basis. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. Research analysts expect that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be issued a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 4.7%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is presently 116.09%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.